Other languages enGene Holdings Inc.

Equities

ENGN

CA29286M1059

End-of-day quote Nasdaq Other stock markets 18:00:00 2024-05-27 EDT			5-day change	1st Jan Change
12.57 ^USD	-2.26%		-4.34%	+36.19%

05-15	EnGene Holdings Inc. Approves Board Appointments	CI
04-22	Wells Fargo Starts enGene Holdings With Overweight Rating, $30 Price Target	MT

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

EnGene to Present at the Jefferies Global Healthcare Conference	05-29
EnGene Announces the Election of Paul Hastings and Wouter Joustra to its Board of Directors	05-15
EnGene Holdings Inc. Approves Board Appointments	05-15
EnGene to Present Details of its Pivotal Phase 1/2 LEGEND Study of EG-70 in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer with Carcinoma in situ at the American Urology Association 2024 Annual Meeting	05-02
Wells Fargo Starts enGene Holdings With Overweight Rating, $30 Price Target	04-22
Guggenheim Starts enGene Holdings With Buy Rating, $34 Price Target	04-15
EnGene Announces Hiring of Dr. Raj Pruthi as Senior Vice President, Urologic Oncology and Clinical Development	04-10
/C O R R E C T I O N -- enGene Inc./	04-09
EnGene Holdings Inc. Appoints Raj Pruthi as SVP, Urologic Oncology and Clinical Development	04-09
UBS Initiates Coverage on enGene Holdings With Buy Rating, $37 Price Target	03-28
EnGene Reports First Quarter 2024 Financial Results and Recent Corporate Progress	03-11
EnGene Holdings Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024	03-11
EnGene : Reports First Quarter 2024 Financial Results and Recent Corporate Progress - Form 8-K	03-11
Morgan Stanley Starts Coverage on Engene With Overweight Rating, $40 Price Target	03-08
EnGene To Present at the Leerink Partners Global Biopharma Conference	03-05
Leerink Partners Starts enGene Holdings With Outperform Rating, $31 Price Target	02-20
EnGene Holdings Inc. announced that it has received CAD 200 million in funding from a group of investors	02-19
Top Midday Gainers	02-14
EnGene Announces Oversubscribed $200 Million Private Placement Financing	02-14
EnGene Announces Leadership Succession Plan	02-14

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages enGene Holdings Inc.

Equities

ENGN

CA29286M1059

Other languages

Filters